Savara, Inc. (SVRA)
5.30
-0.02
(-0.38%)
USD |
NASDAQ |
Sep 11, 16:00
5.305
0.00 (0.00%)
After-Hours: 20:00
Savara Price : 5.30 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 5.38 | 5.395 | 5.27 | 5.30 | 1.064M |
| Sep 10, 2026 | 5.34 | 5.46 | 5.24 | 5.32 | 1.525M |
| Sep 09, 2026 | 5.48 | 5.57 | 5.37 | 5.415 | 1.095M |
| Sep 08, 2026 | 5.27 | 5.63 | 5.26 | 5.53 | 1.661M |
| Sep 04, 2026 | 5.32 | 5.39 | 5.31 | 5.37 | 625457.0 |
| Sep 03, 2026 | 5.52 | 5.52 | 5.29 | 5.37 | 1.240M |
| Sep 02, 2026 | 5.47 | 5.56 | 5.365 | 5.46 | 1.217M |
| Sep 01, 2026 | 5.32 | 5.405 | 5.29 | 5.35 | 1.042M |
| Aug 31, 2026 | 5.25 | 5.44 | 5.21 | 5.39 | 1.959M |
| Aug 28, 2026 | 5.48 | 5.51 | 5.25 | 5.26 | 1.336M |
| Aug 27, 2026 | 5.59 | 5.66 | 5.485 | 5.49 | 1.596M |
| Aug 26, 2026 | 5.58 | 5.68 | 5.51 | 5.61 | 1.530M |
| Aug 25, 2026 | 5.69 | 5.72 | 5.52 | 5.60 | 1.609M |
| Aug 24, 2026 | 5.60 | 5.60 | 5.425 | 5.56 | 1.324M |
| Aug 21, 2026 | 5.54 | 5.64 | 5.50 | 5.59 | 3.035M |
| Aug 20, 2026 | 5.52 | 5.59 | 5.26 | 5.49 | 2.542M |
| Aug 19, 2026 | 5.49 | 5.60 | 5.395 | 5.58 | 1.298M |
| Aug 18, 2026 | 5.33 | 5.43 | 5.285 | 5.37 | 1.510M |
| Aug 17, 2026 | 5.39 | 5.43 | 5.285 | 5.37 | 1.207M |
| Aug 14, 2026 | 5.25 | 5.40 | 5.14 | 5.38 | 1.650M |
| Aug 13, 2026 | 5.75 | 5.79 | 5.25 | 5.27 | 1.874M |
| Aug 12, 2026 | 5.91 | 5.92 | 5.575 | 5.70 | 1.175M |
| Aug 11, 2026 | 5.81 | 5.98 | 5.53 | 5.57 | 1.264M |
| Aug 10, 2026 | 5.82 | 5.93 | 5.63 | 5.73 | 1.207M |
| Aug 07, 2026 | 5.87 | 5.99 | 5.785 | 5.83 | 1.586M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 143.72 |
| Insmed, Inc. | 129.41 |
| United Therapeutics Corp. | 497.11 |
| Vertex Pharmaceuticals, Inc. | 515.44 |
| ACADIA Pharmaceuticals, Inc. | 27.83 |
Price Related Metrics
| PEG Ratio | -0.7414 |
| Price to Book Value | 7.578 |
| Earnings Yield | -10.88% |
| Market Cap | 1.089B |
| PEGY Ratio | -0.7414 |